» Articles » PMID: 30798814

Hepcidin, Iron, and Bacterial Infection

Overview
Journal Vitam Horm
Date 2019 Feb 26
PMID 30798814
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Hepcidin, an oligopeptide, has two major functions in mammals. Hepcidin regulates iron homeostasis by controlling iron export from absorptive enterocytes, hepatocytes, and macrophages into the circulation via ferroportin inactivation. Hepcidin is also an innate antimicrobial agent that is induced by invasive bacteria, limits bacterial proliferation by reducing iron in plasma and extracellular fluids, and kills bacteria. Herein, we review hepcidin and hepcidin genes, iron acquisition by bacteria, hepcidin actions in mice infected with selected extracellular and intracellular bacteria, and reports of corresponding serious human infections. We discuss the relevance and uncertainties of mouse infection models to understanding serious infection of humans with iron overload by the same bacterial species.

Citing Articles

Iron-related Biomarkers in the Diagnosis and Management of Iron Disorders.

Semenova Y, Bjorklund G, Butnariu M, Peana M Curr Med Chem. 2024; 31(27):4233-4248.

PMID: 38415440 DOI: 10.2174/0109298673263003231228060800.


Biofilm Microenvironment Activated Antibiotic Adjuvant for Implant-Associated Infections by Systematic Iron Metabolism Interference.

Ding J, Wang X, Liu W, Ding C, Wu J, He R Adv Sci (Weinh). 2024; 11(17):e2400862.

PMID: 38408138 PMC: 11077648. DOI: 10.1002/advs.202400862.


Mechanism of Iron Ion Homeostasis in Intestinal Immunity and Gut Microbiota Remodeling.

Bao H, Wang Y, Xiong H, Xia Y, Cui Z, Liu L Int J Mol Sci. 2024; 25(2).

PMID: 38255801 PMC: 10815743. DOI: 10.3390/ijms25020727.


Key players in the regulation of iron homeostasis at the host-pathogen interface.

Ullah I, Lang M Front Immunol. 2023; 14:1279826.

PMID: 37942316 PMC: 10627961. DOI: 10.3389/fimmu.2023.1279826.


An Update on the Therapeutic Potential of Antimicrobial Peptides against Infections.

Rangel K, Lechuga G, Provance Jr D, Morel C, De Simone S Pharmaceuticals (Basel). 2023; 16(9).

PMID: 37765087 PMC: 10537560. DOI: 10.3390/ph16091281.